delighted...fck me
Lorus Therapeutics names Whitehead to board 2011-04-07 08:38 ET - News Release Dr. Aiping Young reports LORUS THERAPEUTICS APPOINTS WARREN WHITEHEAD TO BOARD OF DIRECTORS Lorus Therapeutics Inc. is appointing Warren Whitehead to the Lorus board of directors. Mr. Whitehead will also serve as chairman of the audit committee. Mr. Whitehead has held senior financial management positions in several biotechnology and pharmaceutical companies. Most recently he served as chief financial officer of ARIUS Research Inc., providing financial guidance and leadership during the acquisition of ARIUS by Roche in 2008. Prior to that Mr. Whitehead was CFO at Labopharm Inc., where he completed a series of public equity financings and a Nasdaq Stock Market initial public offering. He is currently a member of the board of directors of PlantForm Corp., a life sciences company that develops biosimilar antibody drugs for treatment of cancer and other critical illnesses. "We are delighted to welcome Warren to our board of directors. His financial insight and expertise will be valuable as we pursue our financing goals for 2011," said Dr. Aiping Young, Lorus's president and chief executive officer. We seek Safe Harbor. 2015 Canjex Publishing Ltd. All rights reserved.